{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T00:47:06Z","timestamp":1790470026063,"version":"4.1.0"},"reference-count":29,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,6,1]]},"abstract":"<jats:p>Objective. To study the epidemiologic, clinical, laboratory, and radiologic features, prognostic indicators, and short-term to medium-term outcomes for children with severe acute respiratory syndrome (SARS) and to validate the performance characteristics of a clinical case definition, calculated with respect to SARS-associated coronavirus (SARS-CoV) seroconversion.<\/jats:p><jats:p>Methods. Children &amp;lt;18 years of age, from a single-site outbreak, who satisfied a clinical case definition for SARS, with subsequent serologic confirmation, were treated according to a standard protocol and prospectively monitored.<\/jats:p><jats:p>Results. Forty-four children were included. The median age was 12 years. Forty-two children (95.5%) demonstrated an epidemiologic link. Fever, cough, malaise, coryza, sputum production, headache, myalgia, lymphopenia, and elevated lactate dehydrogenase levels were common presenting features. Radiographic findings were nonspecific, but high-resolution computed tomography of the thorax was an early diagnostic aid. A specific reverse transcription-polymerase chain reaction assay for SARS-CoV yielded positive results for &amp;lt;50% of children. Of 9 children who developed hypoxemia, 8 were treated with methylprednisolone. Of 5 children who received intensive care, 3 required assisted ventilation. All children recovered, and serious adverse events in response to treatment were not observed. The outcomes at 3 to 6 months after disease onset, including exercise tolerance, pulmonary functions, and psychologic status, were favorable. An age of &amp;gt;12 years was associated with methylprednisolone therapy for severe illness. After exclusion of the only infant, an age of &amp;gt;12 years was associated with oxygen requirements. Sore throat, high neutrophil count at presentation, and peak neutrophilia were independent factors predicting severe illness. The clinical case definition demonstrated good sensitivity, specificity, and positive and negative predictive values (97.8%, 92.7%, 88%, and 98.7%, respectively) for diagnostic accuracy.<\/jats:p><jats:p>Conclusions. Children are susceptible to SARS-CoV infection. Teenagers resemble adults with respect to disease progression and may develop severe illness. The short-term to medium-term outcomes are good. Sore throat and initial and peak neutrophilia seem to be predictors of severe illness. Our clinical case definition performed well in the epidemic.<\/jats:p>","DOI":"10.1542\/peds.113.6.e535","type":"journal-article","created":{"date-parts":[[2004,8,14]],"date-time":"2004-08-14T00:53:04Z","timestamp":1092444784000},"page":"e535-e543","source":"Crossref","is-referenced-by-count":109,"title":["Severe Acute Respiratory Syndrome Among Children"],"prefix":"10.1542","volume":"113","author":[{"given":"Chi-wai","family":"Leung","sequence":"first","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yat-wah","family":"Kwan","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-wan","family":"Ko","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Our Lady of Maryknoll Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S.","family":"Chiu","sequence":"additional","affiliation":[{"name":"Departments of Paediatrics and Adolescent Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-yee","family":"Loung","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nai-chung","family":"Fong","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai-ping","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yim-wo","family":"Hui","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen K.W.","family":"Law","sequence":"additional","affiliation":[{"name":"Departments of Paediatrics and Adolescent Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilfred H.S.","family":"Wong","sequence":"additional","affiliation":[{"name":"Departments of Paediatrics and Adolescent Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok-hung","family":"Chan","sequence":"additional","affiliation":[{"name":"Microbiology, Queen Mary Hospital, University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.S. Malik","family":"Peiris","sequence":"additional","affiliation":[{"name":"Microbiology, Queen Mary Hospital, University of Hong Kong, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilina W.L.","family":"Lim","sequence":"additional","affiliation":[{"name":"Government Virus Unit, Public Health Laboratory Centre, Department of Health, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-lung","family":"Lau","sequence":"additional","affiliation":[{"name":"Departments of Paediatrics and Adolescent Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man-chun","family":"Chiu","sequence":"additional","affiliation":[{"name":"Department of Paediatrics and Adolescent Medicine, Princess Margaret Hospital, Hong Kong"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2004,6,1]]},"reference":[{"key":"2021121006343081500_R1","unstructured":"World Health Organization. Cumulative number of reported probable cases of SARS. Available at: www.who.int\/csr\/sars\/country\/2003_06_23\/en\/. Accessed October 10, 2003"},{"key":"2021121006343081500_R2","doi-asserted-by":"crossref","unstructured":"Hon KLE, Leung CW, Cheng WTF, et al. Clinical presentations and outcome of severe acute respiratory syndrome in children. Lancet.2003;361:1701\u20131703","DOI":"10.1016\/S0140-6736(03)13364-8"},{"key":"2021121006343081500_R3","doi-asserted-by":"crossref","unstructured":"Chiu WK, Cheung PCH, Ng KL, et al. Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong. Pediatr Crit Care Med.2003;4:279\u2013283","DOI":"10.1097\/01.PCC.0000077079.42302.81"},{"key":"2021121006343081500_R4","doi-asserted-by":"crossref","unstructured":"Bitnun A, Allen U, Heurter H, et al. Children hospitalized with severe acute respiratory syndrome-related illness in Toronto. Pediatrics.2003;112(4). Available at: www.pediatrics.org\/cgi\/content\/full\/112\/4\/e261","DOI":"10.1542\/peds.112.4.e261"},{"key":"2021121006343081500_R5","unstructured":"World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: www.who.int\/csr\/sars\/casedefinition\/en. Accessed October 10, 2003"},{"key":"2021121006343081500_R6","doi-asserted-by":"crossref","unstructured":"Peiris JSM, Lai ST, Poon LLM, et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet.2003;361:1319\u20131325","DOI":"10.1016\/S0140-6736(03)13077-2"},{"key":"2021121006343081500_R7","doi-asserted-by":"crossref","unstructured":"Tsang OT, Chau TN, Choi KW, et al. Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality. Emerg Infect Dis.2003;9:1381\u20131387","DOI":"10.3201\/eid0911.030400"},{"key":"2021121006343081500_R8","doi-asserted-by":"crossref","unstructured":"Peiris JSM, Chu CM, Cheng VCC, et al. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet.2003;361:1767\u20131772","DOI":"10.1016\/S0140-6736(03)13412-5"},{"key":"2021121006343081500_R9","unstructured":"Department of Health, Hong Kong Special Administrative Region. Outbreak of severe acute respiratory syndrome (SARS) at Amoy Gardens, Kowloon Bay, Hong Kong: main findings of the investigation. Available at: www.info.gov.hk\/info\/ap\/pdf\/amoy_e.pdf. Accessed October 10, 2003"},{"key":"2021121006343081500_R10","doi-asserted-by":"crossref","unstructured":"Sit SC, Yau EKC, Lam YY, et al. A young infant with severe acute respiratory syndrome. Pediatrics.2003;112(4). Available at: www.pediatrics.org\/cgi\/content\/full\/112\/4\/e257","DOI":"10.1542\/peds.112.4.e257"},{"key":"2021121006343081500_R11","doi-asserted-by":"crossref","unstructured":"Fong NC, Kwan YW, Hui YW, et al. Two adolescent twin sisters with severe acute respiratory syndrome (SARS). Pediatrics.2004;113(2). Available at: www.pediatrics.org\/cgi\/content\/full\/113\/2\/e146","DOI":"10.1542\/peds.113.2.e146"},{"key":"2021121006343081500_R12","unstructured":"World Health Organization. Alert, verification and public health management of SARS in the post-outbreak period. Available at: www.who.int\/csr\/sars\/postoutbreak\/en. Accessed October 10, 2003"},{"key":"2021121006343081500_R13","doi-asserted-by":"crossref","unstructured":"Lee N, Hui D, Wu A, et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med.2003;348:1986\u20131994","DOI":"10.1056\/NEJMoa030685"},{"key":"2021121006343081500_R14","doi-asserted-by":"crossref","unstructured":"Tsang KW, Ho PL, Ooi GC, et al. A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med.2003;348:1977\u20131985","DOI":"10.1056\/NEJMoa030666"},{"key":"2021121006343081500_R15","doi-asserted-by":"crossref","unstructured":"Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med.2003;348:1995\u20132005","DOI":"10.1056\/NEJMoa030634"},{"key":"2021121006343081500_R16","doi-asserted-by":"crossref","unstructured":"Rainer TH, Cameron PA, Smit D, et al. Evaluation of WHO criteria for identifying patients with severe acute respiratory syndrome out of hospital: prospective observational study. BMJ.2003;326:1354\u20131358","DOI":"10.1136\/bmj.326.7403.1354"},{"key":"2021121006343081500_R17","doi-asserted-by":"crossref","unstructured":"Chan PKS, Tam JS, Lam CW, et al. Human metapneumovirus detection in patients with severe acute respiratory syndrome. Emerg Infect Dis.2003;9:1058\u20131063","DOI":"10.3201\/eid0909.030304"},{"key":"2021121006343081500_R18","doi-asserted-by":"crossref","unstructured":"Sidwell RW, Huffman JH, Call EW, et al. Inhibition of murine hepatitis virus infections by the immunomodulator 2,3,5,6,7,8-hexahydro-2-phenyl-8,8-dimethoxy-imidazo[1,2a]pyridine (PR-879\u2013317A). Antimicrob Agents Chemother.1987;31:1130\u20131134","DOI":"10.1128\/AAC.31.7.1130"},{"key":"2021121006343081500_R19","doi-asserted-by":"crossref","unstructured":"Ning Q, Brown D, Parodo J, et al. Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol.1998;160:3487\u20133493","DOI":"10.4049\/jimmunol.160.7.3487"},{"key":"2021121006343081500_R20","unstructured":"van Vonderen MG, Bos JC, Prins JM, et al. Ribavirin in the treatment of severe acute respiratory syndrome (SARS). Neth J Med.2003;61:238\u2013241"},{"key":"2021121006343081500_R21","unstructured":"Health Canada. Management of severe acute respiratory syndrome (SARS) in adults: interim guidance for health care providers. Available at: www.hc-sc.gc.ca\/pphb-dgspsp\/sars-sras\/pdf\/sars-clin-guide-20030703_e.pdf. Accessed October 10, 2003"},{"key":"2021121006343081500_R22","doi-asserted-by":"crossref","unstructured":"Cinatl J, Morgenstern B, Bauer G, et al. Treatment of SARS with human interferons. Lancet.2003;362:293\u2013294","DOI":"10.1016\/S0140-6736(03)13973-6"},{"key":"2021121006343081500_R23","doi-asserted-by":"crossref","unstructured":"Nicholls JM, Poon LLM, Lee KC, et al. Lung pathology of fatal severe acute respiratory syndrome. Lancet.2003;361:1773\u20131778","DOI":"10.1016\/S0140-6736(03)13413-7"},{"key":"2021121006343081500_R24","doi-asserted-by":"crossref","unstructured":"Antonio GE, Wong KT, Hui DSC, et al. Thin-section CT in patients with severe acute respiratory syndrome following hospital discharge: preliminary experience. Radiology.2003;228:810\u2013815","DOI":"10.1148\/radiol.2283030726"},{"key":"2021121006343081500_R25","doi-asserted-by":"crossref","unstructured":"Atton AV, Tunnessen WW Jr. Alopecia in children: the most common causes. Pediatr Rev.1990;12:25\u201330","DOI":"10.1542\/pir.12-1-25"},{"key":"2021121006343081500_R26","doi-asserted-by":"crossref","unstructured":"Sperling LC, Mezebish DS. Hair diseases. Med Clin N Am.1998;82:1155\u20131169","DOI":"10.1016\/S0025-7125(05)70408-9"},{"key":"2021121006343081500_R27","doi-asserted-by":"crossref","unstructured":"Bernstein GM, Crollick JS, Hassett JM Jr. Postfebrile telogen effluvium in critically ill patients. Crit Care Med.1988;16:98\u201399","DOI":"10.1097\/00003246-198801000-00020"},{"key":"2021121006343081500_R28","doi-asserted-by":"crossref","unstructured":"Tsui PT, Kwok ML, Yuen H, Lai ST. Severe acute respiratory syndrome: clinical outcome and prognostic correlates. Emerg Infect Dis.2003;9:1064\u20131069","DOI":"10.3201\/eid0909.030362"},{"key":"2021121006343081500_R29","doi-asserted-by":"crossref","unstructured":"Choi KW, Chau TN, Tsang O, et al. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med.2003;139:715\u2013723","DOI":"10.7326\/0003-4819-139-9-200311040-00005"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/113\/6\/e535\/1004093\/zpe0060400e535.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/113\/6\/e535\/1004093\/zpe0060400e535.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:40:01Z","timestamp":1682746801000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/113\/6\/e535\/64407\/Severe-Acute-Respiratory-Syndrome-Among-Children"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6,1]]},"references-count":29,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2004,6,1]]},"published-print":{"date-parts":[[2004,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.113.6.e535","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,6,1]]}}}